Home » Topics » Regulatory

Regulatory
RSS

FDA approves production of [11C]-choline injection for PET imaging

Sep. 14, 2012

FDA approves Genzyme's MS therapeutic

Sep. 13, 2012

FDA approves Pfizer's bosutinib for CML

Sep. 5, 2012

Teduglutide receives European marketing authorization for short bowel syndrome

Sep. 5, 2012

FDA approves Xtandi for metastatic castration-resistant prostate cancer

Sep. 3, 2012

New drug approved for IBS-C and CIC

Aug. 31, 2012

Nucynta ER approved for new indication in U.S.

Aug. 30, 2012

European Commission approves Zinforo

Aug. 29, 2012

NeutroPhase cleared for use in new indications

Aug. 28, 2012

FDA approves new combination pill for HIV

Aug. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...